McManaman C, Novak B, Paul L, Rooney S
PM R. 2024; 17(2):222-237.
PMID: 39311403
PMC: 11826970.
DOI: 10.1002/pmrj.13255.
Petracca M, Petsas N, Sellitto G, Ruotolo I, Livi C, Bonanno V
Front Neurol. 2024; 15:1394867.
PMID: 39175758
PMC: 11338795.
DOI: 10.3389/fneur.2024.1394867.
Taul-Madsen L, Hvid L, Sellebjerg F, Romme Christensen J, Ratzer R, Sejbaek T
BMJ Open. 2024; 14(8):e085241.
PMID: 39153792
PMC: 11331840.
DOI: 10.1136/bmjopen-2024-085241.
Skjerbaek A, Dalgas U, Stenager E, Boesen F, Hvid L
Mult Scler J Exp Transl Clin. 2023; 9(4):20552173231218127.
PMID: 38105806
PMC: 10722939.
DOI: 10.1177/20552173231218127.
Al-Naqeb G, Kalmpourtzidou A, De Giuseppe R, Cena H
Nutrients. 2023; 15(22).
PMID: 38004221
PMC: 10674509.
DOI: 10.3390/nu15224827.
An Overview of Physical Exercise Program Protocols and Effects on the Physical Function in Multiple Sclerosis: An Umbrella Review.
Sortino M, Petrigna L, Trovato B, Amato A, Castorina A, DAgata V
J Funct Morphol Kinesiol. 2023; 8(4).
PMID: 37987490
PMC: 10660496.
DOI: 10.3390/jfmk8040154.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana J, Prieto Gonzalez J, Caminero Rodriguez A, Olascoaga Urtaza J, Alonso A, Duran Ferreras E
Neurol Ther. 2023; 12(6):2177-2193.
PMID: 37861931
PMC: 10630277.
DOI: 10.1007/s40120-023-00557-7.
Pain in patients with multiple sclerosis.
Kasap Z, Ugurlu H
Turk J Phys Med Rehabil. 2023; 69(1):31-39.
PMID: 37200999
PMC: 10186022.
DOI: 10.5606/tftrd.2022.10524.
Measuring objective fatigability and autonomic dysfunction in clinical populations: How and why?.
Millet G, Bertrand M, Lapole T, Feasson L, Rozand V, Hupin D
Front Sports Act Living. 2023; 5:1140833.
PMID: 37065809
PMC: 10101442.
DOI: 10.3389/fspor.2023.1140833.
A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis.
Morris M, Chye R, Liu Z, Agar M, Razmovski-Naumovski V
J Clin Med. 2023; 12(4).
PMID: 36836018
PMC: 9965412.
DOI: 10.3390/jcm12041483.
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis.
Ziccardi S, Pizzini F, Guandalini M, Tamanti A, Cristofori C, Calabrese M
Bioengineering (Basel). 2023; 10(1).
PMID: 36671613
PMC: 9855175.
DOI: 10.3390/bioengineering10010041.
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.
Jakimovski D, Kavak K, Zakalik K, Bromley L, Ozel O, Qutab N
Mult Scler J Exp Transl Clin. 2022; 8(2):20552173221099186.
PMID: 35571975
PMC: 9102142.
DOI: 10.1177/20552173221099186.
Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study.
Hvid L, Stenager E, Dalgas U
J Neurol. 2022; 269(9):4895-4908.
PMID: 35482080
DOI: 10.1007/s00415-022-11134-7.
The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.
Gustavsen S, Olsson A, Sondergaard H, Andresen S, Sorensen P, Sellebjerg F
BMC Neurol. 2021; 21(1):317.
PMID: 34399707
PMC: 8365982.
DOI: 10.1186/s12883-021-02344-z.
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
Meca-Lallana J, Maurino J, Perez-Miralles F, Forero L, Sepulveda M, Calles C
PLoS One. 2021; 16(7):e0255317.
PMID: 34324586
PMC: 8320986.
DOI: 10.1371/journal.pone.0255317.
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review.
Lakin L, Davis B, Binns C, Currie K, Rensel M
Neurol Ther. 2021; 10(1):75-98.
PMID: 33877583
PMC: 8057008.
DOI: 10.1007/s40120-021-00239-2.
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance.
Zackowski K, Freeman J, Brichetto G, Centonze D, Dalgas U, DeLuca J
Mult Scler. 2021; 27(7):989-1001.
PMID: 33720795
PMC: 8151585.
DOI: 10.1177/1352458521999970.
Personalised inpatient multidisciplinary rehabilitation elicits clinically relevant improvements in physical function in patients with multiple sclerosis - The Danish MS Hospitals Rehabilitation Study.
Hvid L, Gaemelke T, Dalgas U, Slipsager M, Rasmussen P, Petersen T
Mult Scler J Exp Transl Clin. 2021; 7(1):2055217321989384.
PMID: 33643662
PMC: 7894699.
DOI: 10.1177/2055217321989384.
Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.
Martinez-Lopez I, Maurino J, Sanmartin-Fenollera P, Ontanon-Nasarre A, Santiago-Perez A, Moya-Carmona I
Pharmacy (Basel). 2020; 8(2).
PMID: 32272683
PMC: 7356901.
DOI: 10.3390/pharmacy8020061.
Central Neuropathic Pain and Profiles of Quantitative Electroencephalography in Multiple Sclerosis Patients.
Krupina N, Churyukanov M, Kukushkin M, Yakhno N
Front Neurol. 2020; 10:1380.
PMID: 32038459
PMC: 6990108.
DOI: 10.3389/fneur.2019.01380.